Business Wire

NetApp Powers Porsche Motorsport to ABB FIA Formula E World Championship Wins with Data-driven Cloud Solutions

13.7.2022 15:00:00 EEST | Business Wire | Press release

Share

NetApp® (NASDAQ: NTAP), a global cloud-led, data-centric software company, and TAG Heuer Porsche Formula E Team, today announced a multi-year partnership. NetApp will provide the sportscar maker with innovative hybrid cloud solutions that will help them continue to write car racing history.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220713005218/en/

Porsche AG, a global automotive brand owned by Volkswagen Group, has begun shifting production towards electric or e-fuel powered vehicles in 2015. By the year 2030, Porsche AG aims for 80% of all vehicles sold to be electric. Tapping into NetApp’s real-time data services, TAG Heuer Porsche Formula E Team helps deliver on the vision of sustainable mobility while enabling the real-time adjustments that deliver superior race performance – and help drive the next generation of Porsche electric vehicles.

Real-time data collaboration service for the racetrack

NetApp's hybrid cloud solutions enable TAG Heuer Porsche Formula E Team to access their data trackside to support driver and team performance. This helps them make data-driven decisions in real-time, for example when to use the Formula E Attack Mode, which unlocks an additional 30 kilowatts of engine power. The rules about engaging Attack Mode are set by FIA shortly before every ePrix, hence it has a great impact on race strategy.

With data at the core of racing, business, and engineering decisions, the TAG Heuer Porsche Formula E Team requires cutting-edge data management technology:

  • Data and systems need to be available at the racetrack and fulfill demanding performance requirements.
  • Digital data collected during the ePrix must be uploaded to the cloud for analysis while the race is still running.
  • Cloud data needs to be processed by the team at Porsche Motorsport headquarters in Weissach, Germany for R&D.
  • After the race, data must be transferred to the cloud so it can be utilized in the future, and to support crucial data services such as backup and archiving.

The hybrid cloud data solution designed by NetApp and Porsche in response combines cloud network-attached (NAS) storage services with Global File Cache to ensure data can flow seamlessly and quickly between different widely dispersed locations. It also integrates powerful NetApp data services to ensure version consistency, manage and monitor cloud resources, and protect Porsche’s intellectual property:

  • Cloud Volumes ONTAP is the primary storage platform for TAG Heuer Porsche Formula E Team. The multicloud solution deployed on Azure acts as a hub that consolidates all the team’s data.
  • Global File Cache, the cloud volume edge capability provides local edge instances, enabling low-latency access to a common dataset, both at the on-premises development center in Weissach and the racetrack.
  • Cloud Manager delivers centralized orchestration across hybrid cloud storage infrastructure and all data management services, so that TAG Heuer Porsche Formula E Team can manage, monitor and automate all their data software and hardware consumption.
  • Cloud Backup integrates as backup and archive layer for the consolidated cloud data.

“Formula E is a technology showcase and R&D backbone for Porsche and preserves our strong motorsports heritage on the road and on the track,” said Friedemann Kurz, Head of Motorsport IT, Porsche. “Data is the defining element here, but it is not easy to harness when the racing team is always on the road. The solution created by NetApp is unique in the market in how it can move huge amounts of data at high speed while delivering an intuitive experience across edge, core and cloud so we can design better, faster cars for our racecar drivers and car enthusiasts everywhere.”

“This is a winning partnership in which two champions meet eye-to-eye. Porsche has secured over 30,000 wins in all major car racing series. NetApp has submitted more than 2,500 data innovation patents. Joining forces now, we are working to make our mark on the future of racing,” said James Whitemore, Executive Vice President and Chief Marketing Officer at NetApp. “Digital data is collected by the cars’ many sensors as they dart along the track and is processed synchronously to predict outcomes to aid the trackside team. Data equals speed.”

Additional Resources

About NetApp

NetApp is a global, cloud-led, data-centric software company that empowers organizations to lead with data in the age of accelerated digital transformation. The company provides systems, software and cloud services that enable them to run their applications optimally from data center to cloud, whether they are developing in the cloud, moving to the cloud, or creating their own cloudlike experiences on premises. With solutions that perform across diverse environments, NetApp helps organizations build their own data fabric and securely deliver the right data, services and applications to the right people—anytime, anywhere. Learn more at www.netapp.com or follow us on Twitter, LinkedIn, Facebook, and Instagram.

NETAPP, the NETAPP logo, and the marks listed at www.netapp.com/TM are trademarks of NetApp, Inc.

About Porsche in Formula E

With the Porsche 99X Electric, Porsche returned to open-wheel single-seater racing in 2019 after more than 30 years and celebrated a successful debut scoring second place at the season-opener in Saudi Arabia’s Diriyah in the ABB Formula E season 6. In 2021/2022, the TAG Heuer Porsche Formula E Team contests its third Formula E season with the Porsche 99X Electric – and clinched an historic one-two result in Mexico on 12 February 2022. The fully electric racing car sporting the Weissach-developed Porsche E Performance Powertrain also serves as a development platform for the sports car manufacturer’s fully electric production models. Energy management and efficiency are important factors of success in Formula E and in the development of production cars. For the 2021/2022 season, the 99X Electric has a maximum output of 250 kW in qualification mode and 220 kW (last season 200 kW) in normal race mode. Attack Mode boosts the output to 250 kW (last season 235 kW). Maximum recuperation is 250 kW; the usable battery capacity is 52 Kilowatt-hours.

Formula E is the Fédération Internationale de l'Automobile’s (FIA) innovative and sustainable international championship for electric open-wheel racing cars.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Media Contacts:
Kenya Hayes
NetApp
kenya.hayes@netapp.com

Marvin Sauer
NetApp
marvin.sauer@netapp.com

Viktoria Wohlrapp
Porsche
viktoria.wohlrapp@porsche.de

Investor Contact:
Lance Berger
NetApp
lance.berger@netapp.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Bending Spoons S.p.A. announces filing of registration statement for proposed initial public offering8.6.2026 14:20:00 EEST | Press release

Bending Spoons S.p.A. (“Bending Spoons”), a leading technology company, announces today that it has publicly filed a registration statement on Form F-1 with the U.S. Securities and Exchange Commission (“SEC”) relating to a proposed initial public offering of its ordinary shares. The timing of the offering, number of shares to be offered, and the price range for the proposed offering have not yet been determined. Bending Spoons has applied to list its ordinary shares on the Nasdaq Global Select Market under the ticker symbol “BSP.” Goldman Sachs International, J.P. Morgan, and Allen & Company LLC are acting as joint lead book-running managers for the proposed offering. Wells Fargo Securities, BofA Securities, Jefferies, Evercore ISI, BNP Paribas, Mizuho, Societe Generale, Crédit Agricole CIB, IMI – Intesa Sanpaolo, UniCredit, and Banca Akros – Gruppo Banco BPM are acting as joint book-running managers for the proposed offering. The proposed offering is subject to market and other condit

Xsolla to Attend SuperReturn International 2026 to Advance Strategic Partnerships and Expand Its Presence in Global Private Capital8.6.2026 14:15:00 EEST | Press release

Xsolla, a global leader in video game commerce, today announced its participation in SuperReturn International 2026, taking place June 8–12 at the InterContinental Berlin. Uniting more than 6,000 senior attendees, including 2,000+ LPs and 3,000 GPs, SuperReturn International is widely recognized as the capital of private capital with the best investment opportunities globally. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260607269536/en/ Graphic: Xsolla The video game industry has matured into one of the largest and most resilient segments of the global entertainment economy, outpacing film and music combined, driving continuous growth through shifting market cycles. Yet the infrastructure powering how games are sold, monetized, and distributed worldwide remains under-examined by much of the institutional investment community. Xsolla's presence at SuperReturn International reflects a broader moment: the convergence of a mu

Shilpa Medicare and Gate2Brain Sign Strategic Equity Partnership to Advance First-in-Class Brain Cancer Therapy8.6.2026 13:00:00 EEST | Press release

Shilpa Biocare Pvt Ltd, a Subsidiary of Shilpa Medicare Limited (BSE/NSE: SHILPAMED) has entered a strategic equity partnership with Gate2Brain, S.L., a biotechnology company focused on CNS therapeutics. Shilpa becomes a strategic shareholder and CMC, manufacturing, and regulatory partner for G2B-002 — Gate2Brain's lead program targeting deadly pediatric brain cancers, DIPG and pGBM, both with Orphan Drug Designation from the US FDA and EMA. G2B-002 uses Gate2Brain's proprietary MiniAp4 peptide shuttle to deliver SN-38 across the blood-brain barrier, demonstrating up to 100-fold greater brain drug transport preclinically. First-in-human trials are anticipated by FY28. G2B-002 targets high-growth oncology markets — the glioblastoma market projected at USD 6.48B by 2035 (CAGR: 7.97%), pediatric brain tumors at USD 2.47B by 2031 (CAGR: 6.9%), and DIPG at USD 1.2B by 2035 (CAGR: 7.1%). Gate2Brain's MiniAp4 platform further extends potential across rare pediatric cancers and broader CNS cat

Haleon Invests in India to Deliver Better Everyday Health to Rural Communities8.6.2026 12:11:00 EEST | Press release

Haleon, a consumer company that is solely focused on better everyday health, today announces plans to expand its business in India, one of its fastest-growing markets and key to Haleon delivering its strategy and ambitions to reach one billion more consumers by 2030. Haleon will invest approximately £175 million2 in building a new oral health manufacturing site in Madhya Pradesh, central India and accelerate distribution efforts in rural India to meet rising demand. The new site will also support supply for wider Asia. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260608753094/en/ Haleon Health Ambassador on motorbike, equipped with testing kits, samples and diagnostic tools Building capacity to meet rising demand The new site, which is well-positioned in the middle of the country and close to some of India’s most renowned technical colleges, marks an important step in the delivery of Haleon’s Win as One strategy. Win as On

Diabetology’s Breakthrough Clinical Data From Oraglutide™ Oral GLP-18.6.2026 11:56:00 EEST | Press release

Diabetology Limited (Jersey) poster presentation (https://diabetology.co.uk/ada-poster) 1724-P at the ADA 86th Scientific Session, New Orleans, reporting first human data from Oraglutide™ — small capsule intestinally-released oral semaglutide, formulated using the proprietary Axcess™ delivery technology. KEY HIGHLIGHTS 6-day glucose control: A single 4 mg oral dose of Oraglutide™ produced a sustained fall in glucose. Measuring 14% at Day 6 (p=.046), the longest duration presented from a single oral GLP-1 dose in a human IVGTT study. 28% increase in insulin secretion: Relative to placebo, insulin percent AUC increased by 12% day 0, (p=0.02) & 28% Day 1 (p = 0.025). Novel intestinal depot effect: Blood levels of semaglutide were higher on Day 1 than dosing on Day 0, consistent with lipid associated depot effect in the intestinal wall, a fundamentally new pharmacological finding. No nausea or side effects observed: No adverse events observed across the 8-subject cohort over one week, cons

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye